Revvity's Dharmacon All-in-one lentiviral platform has expanded to include whole-genome library options for CRISPR knockout (CRISPRko), CRISPR interference (CRISPRi), and CRISPR activation (CRISPRa).
SALT LAKE CITY, Jan. 09, 2024 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced its support for the American Society of ...
News Medical on MSN
Direct-to-consumer genetic testing drives preventive care
23andMe Research Institute today announced the publication of a new study highlighting the positive health actions taken by people who learned of their risk through direct-to-consumer genetic testing.
The NCCN's new resource educates patients on genetic testing for hereditary cancer risk, focusing on breast, ovarian, pancreatic, and prostate cancers. Advances in genetic technology, spurred by the ...
SALT LAKE CITY, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in genetic testing and precision medicine, today announced its support for a recent guideline update ...
INFORMATION. WE’RE ALL FAMILIAR WITH THE TERM. IT RUNS IN THE FAMILY. MUCH OF OUR DNA COMES FROM OUR PARENTS, GRANDPARENTS, AND SO FORTH, AND DNA CAN REGULARLY CONTRIBUTE TO HEREDITARY CANCER RISK, ...
Huntsman Cancer Institute genetic counselor Sam Beck, MS, CGC, answers common questions people ask about pancreatic cancer and the genetic testing associated with it. People at an increased risk for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results